Cerity Partners’s Alpha Tau Medical DRTS Stock Holding History

Cerity Partners’s Portfolio DRTS Stock Details DRTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$226K	Buy	+32,012	New	+$226K	﹤0.01%	2807

Other funds holding DRTS

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Aquamarine Financial George Town $1.37B AUM

Apella Capital West Hartford, Connecticut $7.08B AUM 17.38% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Kovitz Investment Group Partners Chicago, Illinois $4.31B AUM 20.41% 1-Year Est. Return

DSC

Daytona Street Capital Saint Louis, Missouri $130M AUM

Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return

GIA

Gem Investment Advisors Teaneck, New Jersey $102M AUM

LCS

Levin Capital Strategies New York $1.32B AUM 28.11% 1-Year Est. Return

Cerity Partners's DRTS Position: Q1 2026 in Review

Cerity Partners opened a new position in Alpha Tau Medical (DRTS) in Q1 2026: 32,012 shares worth $226K. The stake represents ﹤0.01% of the portfolio and ranks #2807 among its holdings.

53 funds tracked by Wall St. Rank hold DRTS as of Q1 2026.

Cerity Partners held 32,012 shares of Alpha Tau Medical worth $226K as of Q1 2026.
Alpha Tau Medical was a new Cerity Partners position in Q1 2026.
Alpha Tau Medical made up ﹤0.01% of Cerity Partners's portfolio in Q1 2026, its #2807 holding.
53 funds tracked by Wall St. Rank held Alpha Tau Medical as of Q1 2026.

Based on Cerity Partners's 13F filing for Q1 2026, filed 15 May 2026.